Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Drugs for Non-small Cell Lung Cancer , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Drugs for Non-small Cell Lung Cancer market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Radiofrequency Ablation (RFA)
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy
By End-User / Application
Hospital
Clinic
Others
By Company
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Sanofi
Ziopharm Oncology
Alchemia
Amgen
Apotex
BioMarin Pharmaceutical
CellAct Pharma
Cerulean Pharma
Cipla
Cornerstone Pharmaceuticals
Curis
CytRx
Eli Lilly
Exelixis
Fresenius Kabi
Genentech
Hikma Pharmaceuticals
Hospira
Intas Pharmaceuticals
Karyopharm Therapeutics
Kyowa Hakko Kirin
Ligand Pharmaceuticals
End of Summary
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Drugs for Non-small Cell Lung Cancer Market and Growth by Type
1.3 by End-Use / Application
Table Global Drugs for Non-small Cell Lung Cancer Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Drugs for Non-small Cell Lung Cancer Revenue (Million USD) by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Revenue Share by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Share Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by Type (2020-2025)
Table Global Drugs for Non-small Cell Lung CancerMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.MSD Bristol-Myers Squibb
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
12.2 GlaxoSmithKline
12.3 Menarini
12.4 Sanofi
12.5 Ziopharm Oncology
12.6 Alchemia
12.7 Amgen
12.8 Apotex
12.9 BioMarin Pharmaceutical
12.10 CellAct Pharma
12.11 Cerulean Pharma
12.12 Cipla
12.13 Cornerstone Pharmaceuticals
12.14 Curis
12.15 CytRx
12.16 Eli Lilly
12.17 Exelixis
12.18 Fresenius Kabi
12.19 Genentech
12.20 Hikma Pharmaceuticals
12.21 Hospira
12.22 Intas Pharmaceuticals
12.23 Karyopharm Therapeutics
12.24 Kyowa Hakko Kirin
12.25 Ligand Pharmaceuticals
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion
List of Tables and Figures
List of Table
Table Global Drugs for Non-small Cell Lung Cancer Market and Growth by Type
Table Global Drugs for Non-small Cell Lung Cancer Market and Growth by End-Use / Application
Table Global Drugs for Non-small Cell Lung Cancer Revenue (Million USD) by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Revenue Share by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Regions (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Share Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by Type (2020-2025)
Table Global Drugs for Non-small Cell Lung CancerMarket Share by Forecast Type (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Menarini
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of Ziopharm Oncology
Table Sales Revenue, Volume, Price, Cost and Margin of Alchemia
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen
Table Sales Revenue, Volume, Price, Cost and Margin of Apotex
Table Sales Revenue, Volume, Price, Cost and Margin of BioMarin Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of CellAct Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Cerulean Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Cipla
Table Sales Revenue, Volume, Price, Cost and Margin of Cornerstone Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Curis
Table Sales Revenue, Volume, Price, Cost and Margin of CytRx
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of Exelixis
Table Sales Revenue, Volume, Price, Cost and Margin of Fresenius Kabi
Table Sales Revenue, Volume, Price, Cost and Margin of Genentech
Table Sales Revenue, Volume, Price, Cost and Margin of Hikma Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Hospira
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Karyopharm Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Kyowa Hakko Kirin
Table Sales Revenue, Volume, Price, Cost and Margin of Ligand Pharmaceuticals
List of Figure
Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Drugs for Non-small Cell Lung Cancer Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) and Growth Forecast (2020-2025)